- Leidos Holdings Inc LDOS reported fourth-quarter FY21 revenue growth of 7% year-on-year to $3.49 billion, missing the consensus of $3.51 billion. Revenue grew 6% organically.
- The most significant revenue contributors were the increase in veterans' disability examinations after the pause from the pandemic and the start-up of the Navy NGEN-R SMIT contract.
- Defense Solutions' revenue rose 7% Y/Y to $2.06 billion. Civil revenue fell 1% at $800 million. Health revenue expanded 23% Y/Y to $630 million.
- Net bookings totaled $3.2 billion, representing a book-to-bill ratio of 0.9. As a result, the backlog was $34.5 billion.
- The adjusted EBITDA margin contracted by 100 bps to 10.3%.
- Non-GAAP EPS of $1.56 missed the consensus of $1.60.
- Leidos held $727 million in cash and equivalents and generated $210 million in operating cash flow.
- Dividend & Share Buyback: The board declared a cash dividend of $0.36 per share.
- The board also authorized a stock repurchase program of up to 20 million shares.
- Outlook: Leidos sees FY22 revenue of $13.9 billion - $14.3 billion, below the consensus of $14.38 billion.
- Leidos sees non-GAAP EPS of $6.10 - $6.50, below the consensus of $6.85.
- Price Action: LDOS shares closed lower by 1.83% at $87.36 on Monday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in